MapLight Therapeutics (MPLT) Non-cash Items (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Non-cash Items came in at $38.2 million in Q4 2025, up 205.92% year-on-year from $12.5 million in Q4 2024, and up 827.18% quarter-over-quarter from $4.1 million in Q3 2025.
MapLight Therapeutics (MPLT) Non-cash Items (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Non-cash Items across 2 years of filings, most recently posting $38.2 million for Q4 2025.
- Non-cash Items for Q4 2025 came in at $38.2 million, up 205.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $38.2 million (up 205.92% YoY), and the FY2025 annual result was $38.2 million, up 205.92% from the prior year.
- Non-cash Items came in at $38.2 million for Q4 2025 at MapLight Therapeutics, up from $4.1 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $38.2 million in Q4 2025 to a low of $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.20 Mn |
| Dec 31, 2025 | 38.20 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Dec 31, 2024 | 12.49 Mn |
| Dec 31, 2024 | 12.49 Mn |